Discovery of a biologically active thiostrepton fragment

Journal of the American Chemical Society

Volumn 127, Issue 43, 2005, Pages 15042-15044

  Nicolaou, K C ^b   Zak, Mark ^b   Rahimipour, Shai ^b   Estrada, Anthony A ^b   Lee, Sang Hyup ^b   O'Brate, Aurora ^a   Giannakakou, Paraskevi ^a   Ghadiri, M Reza ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TEICOPLANIN; THIOSTREPTON; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG SYNTHESIS; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN;

ANIMALS; ANTI-BACTERIAL AGENTS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HUMANS; MODELS, CHEMICAL; PEPTIDES; PLASMODIUM FALCIPARUM; STAPHYLOCOCCUS; THIOSTREPTON;

EID: 27544455748     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja0552803     Document Type: Article

References (36)

1. Dennis, S. M.; Nagaraja, T. G.; Dayton, A. D. Res. Vet. Sci. 1986, 41, 251-256.
2. Jonghee, K. PCT Int. Appl. WO 2002066046, [CAN 137: 195555], 2002.
3. (a) McConkey, G. A.; Rogers, M. J.; McCutchan, T. F. J. Biol. Chem. 1997, 272, 2046-2049.
4. (b) Hardman, J. G.; Limbird, L. E.; Molinoff, P. B.; Ruddon, R. W. A.; Gilman, G. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed.: The McGraw-Hill Companies: New York, 1996; pp 965-985.
5. Ueno, M.; Furukawa, S.; Abe, F.; Ushioda, M.; Fujine, K.; Johki, S.; Hatori, H.; Ueda, J. J. Antibiot. 2004, 57, 590-596.
6. Isolation: (a) Pagano, J. F.; Weinstein, M. J.; Stout, H. A.; Donovick, R. Antibiot. Ann. 1955-1956, 554-559.
7. (b) Vandeputte, J.; Dutcher, J. D. Antibiot. Ann. 1955-1956, 560-561.
8. (c) Steinberg, B. A.; Jambor, W. P.; Suydam, L. O. Antihiot. Ann. 1955-1956, 562-565.
9. Structure determination: (d) Bond, C. S.; Shaw, M. P.; Alphey, M. S.; Hunter, W. N. Acta Crystallogr. 2001, D57, 755-758.
10. (e) Anderson, B.; Hodgkin, D. C.; Viswamitra, M. A. Nature 1970, 225, 233-235.
11. (f) Hensens, O. D.; Albers-Schönberg, G. J. Antibiot. 1983, 36, 799-813.
12. (g) Hensens, O. D.; Albers-Schönberg, G. J. Antibiot. 1983, 36, 814-831.
13. (h) Hensens, O. D.; Albers-Schönberg, G. J. Antibiot. 1983, 36, 732-845.
14. The chemistry, biology, and medicine of the thiopeptide antibiotics have recently been reviewed: Bagley, M. C.; Dale, J. W.; Merritt, E. A.; Xiong, X. Chem. Rev. 2005, 105, 685-714.
15. (a) Nicolaou, K. C.; Zak, M.; Safina, B. S.; Estrada, A. A.; Lee, S. H.; Nevalainen, M. J. Am. Chem. Soc. 2005, 127, 11176-11183.
16. (b) Nicolaou, K. C.; Safina, B. S.; Zak, M.; Lee, S. H.; Nevalainen, M.; Bella, M.; Estrada, A. A.; Funke, C.; Zécri, F.; Bulat, S. J. Am. Chem. Soc. 2005, 127, 11159-11175.
17. (c) Nicolaou, K. C.; Zak, M.; Safina, B. S.; Lee, S. H.; Estrada, A. A. Angew. Chem., Int. Ed. 2004, 43, 5092-5097.
18. (d) Nicolaou, K. C.; Safina, B. S.; Zak, M.; Estrada, A. A.; Lee, S. H. Angew. Chem., Int. Ed. 2004, 43, 5087-5092.
19. (e) Nicolaou, K. C.; Nevalainen, M.; Zak, M.; Bulat, S.; Bella, M.; Safina, B. S. Angew. Chem., Int. Ed. 2003, 42, 3418-3424.
20. (f) Nicolaou, K. C.; Nevalainen, M.; Safina, B. S.; Zak, M.; Bulat, S. Angew. Chem., Int. Ed. 2002, 41, 1941-1945.
21. (g) Nicolaou, K. C.; Safina, B. S.; Funke, C.; Zak, M.; Zécri, F. J. Angew. Chem., Int. Ed. 2002, 41, 1937-1940.
22. (a) Xing, Y.; Draper, D. E. Biochemistry 1996, 35, 1581-1588.
23. (b) Bowen, W. S.; Van Dyke, N.; Murgola, E. J.; Lodmell, J. S.; Hill, W. E. J. Biol. Chem. 2005, 280, 2934-2943.
24. (a) de la Torre, B. G.; Torres, J. E.; Bardají, E.; Clapés, P.; Xaus, N.; Jorba, X.; Calvet, S.; Albericio, F.; Valencia, G. J. Chem. Soc., Chem. Commun. 1990, 965-967.
25. (b) For a review on the use and removal of allylic protecting groups, see: Guibé, F. Tetrahedron 1998, 54, 2967-3042.
26. Strazzolini, P.; Verardo, G.; Giumanini, A. G. J. Org. Chem. 1988, 53, 3321-3325.
27. The configuration of the newly formed stereocenter was assigned by NOE studies of a peptide-coupled derivative (see ref 7f).
28. See Supporting Information for assay details.
29. (a) Bower, J.; Drysdale, M.; Hebdon, R.; Jordan, A.; Lentzen, G.; Matassov, N.; Murchie, A.; Powles, J.; Roughley, S. Bioorg. Med. Chem. Lett. 2003, 13, 2455.
30. (b) Ayida, B. K.; Simonsen, K. B.; Vourloumis, D.; Hermann, T. Bioorg. Med. Chem. Lett. 2005, 15, 2457-2460.
31. (a) Han, Q.; Zhao, Q.; Fish, S.; Simonsen, K. B.; Vourloumis, D.; Froelich, J. M.; Wall, D.; Hermann, T. Angew. Chem., Int. Ed. 2005, 44, 2694-2700.
32. (b) Zhao, F.; Zhao, Q.; Blount, K.; Han, Q.; Tor, Y.; Hermann, T. Angew. Chem., Int. Ed. 2005, 44, 2-6.
33. (c) Greenberg, W. A.; Priestley, E. S.; Sears, P. S.; Alper, P. B.; Rosenbohm, C.; Hendrix, M.; Hung, S.-C.; Wong, C.-H. J. Am. Chem. Soc. 1999, 121, 6527-6541.
34. (d) Aminoglycoside Antibiotics; Umezawa, H., Hooper, I. R., Eds.; Springer-Verlag: New York, Heidelberg, 1982.
35. Skehan, P.; Storeng, R.; Scuderio, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
36. Scudiero, D. A.; Shoemaker, R. H.; Paull, K. D.; Monks, A.; Tierney, S.; Nofziger, T. H.; Currens, M. J.; Seniff, D.; Boyd, M. R. Cancer Res. 1988, 48, 4827-4833.